CPC C12N 15/86 (2013.01) [A61K 48/005 (2013.01); A61P 25/00 (2018.01); C07K 14/47 (2013.01); C12N 7/00 (2013.01); C12N 2750/14123 (2013.01); C12N 2750/14143 (2013.01)] | 20 Claims |
1. A method of delivering a payload to a tissue of the central nervous system (CNS) in a mammalian subject, wherein the method comprises: administering a first adeno-associated virus (AAV) particle to the subject by intravenous (IV) administration at a dose of at least 2.00×1013 vg/kg; wherein the first AAV particle comprises:
(i) an AAV capsid comprising the amino acid sequence of SEQ ID NO: 2; and
(ii) a viral genome comprising at least one inverted terminal repeat (ITR) and a polynucleotide sequence encoding the payload.
|